Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
- PMID: 27217435
- DOI: 10.1161/CIRCULATIONAHA.115.021158
Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
Comment in
-
Letter by Petrie Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".Circulation. 2016 Oct 11;134(15):e332-e333. doi: 10.1161/CIRCULATIONAHA.116.023847. Circulation. 2016. PMID: 27753618 No abstract available.
-
Response by Bagai et al to Letter Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".Circulation. 2016 Oct 11;134(15):e334-e335. doi: 10.1161/CIRCULATIONAHA.116.024526. Circulation. 2016. PMID: 27753619 No abstract available.
Similar articles
-
Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):347-355. doi: 10.1177/1074248416683048. Epub 2016 Dec 21. J Cardiovasc Pharmacol Ther. 2017. PMID: 28587584 Review.
-
Clopidogrel: the data, the experience, and the controversies.Am J Cardiovasc Drugs. 2012 Dec 1;12(6):361-74. doi: 10.2165/11636340-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 23057989 Review.
-
P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use.J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e9-e12. doi: 10.2459/JCM.0000000000000595. J Cardiovasc Med (Hagerstown). 2018. PMID: 29538137 Review. No abstract available.
-
Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?Intern Med J. 2017 Nov;47(11):1298-1305. doi: 10.1111/imj.13595. Intern Med J. 2017. PMID: 28857445
-
Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome.Trends Cardiovasc Med. 2020 May;30(4):198-202. doi: 10.1016/j.tcm.2019.05.008. Epub 2019 May 31. Trends Cardiovasc Med. 2020. PMID: 31182263 Review.
Cited by
-
Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry.BMC Cardiovasc Disord. 2021 Jun 14;21(1):299. doi: 10.1186/s12872-021-02115-1. BMC Cardiovasc Disord. 2021. PMID: 34126921 Free PMC article.
-
Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study.PLoS One. 2017 Oct 2;12(10):e0185847. doi: 10.1371/journal.pone.0185847. eCollection 2017. PLoS One. 2017. PMID: 28968454 Free PMC article.
-
Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis.BMC Cardiovasc Disord. 2020 Oct 1;20(1):430. doi: 10.1186/s12872-020-01603-0. BMC Cardiovasc Disord. 2020. PMID: 33004000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical